Update
$Genprex (GNPX.US)$ Reuters
3 min ago
Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination With Tecentriq® in Extensive Stage Small Cell Lung Cancer
3 min ago
Genprex Receives Safety Review Committee Approval to Advance to Highest Dose Group in Phase 1 Portion of Acclaim-3 Clinical Trial of Reqorsa® Gene Therapy in Combination With Tecentriq® in Extensive Stage Small Cell Lung Cancer
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
